HK1041518B - Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract - Google Patents

Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract

Info

Publication number
HK1041518B
HK1041518B HK02101648.2A HK02101648A HK1041518B HK 1041518 B HK1041518 B HK 1041518B HK 02101648 A HK02101648 A HK 02101648A HK 1041518 B HK1041518 B HK 1041518B
Authority
HK
Hong Kong
Prior art keywords
extract
lak activity
screening
materials containing
edodes mycelium
Prior art date
Application number
HK02101648.2A
Other languages
Chinese (zh)
Other versions
HK1041518A1 (en
Inventor
Matsuda Yukiko
Tajima Yutaka
Asano Kenji
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Hitoshi Nagaoka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd, Hitoshi Nagaoka filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of HK1041518A1 publication Critical patent/HK1041518A1/en
Publication of HK1041518B publication Critical patent/HK1041518B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02101648.2A 1998-11-27 2002-03-04 Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract HK1041518B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35392698A JP4308350B2 (en) 1998-11-27 1998-11-27 LAK activity screening substance containing shiitake mycelium extract and LAK activity screening method using the same
PCT/JP1999/006615 WO2000033069A1 (en) 1998-11-27 1999-11-26 Substance containing shiitake mushroom hypha extract for screening lak activity and method for screening lak activity by using the same

Publications (2)

Publication Number Publication Date
HK1041518A1 HK1041518A1 (en) 2002-07-12
HK1041518B true HK1041518B (en) 2005-03-24

Family

ID=18434161

Family Applications (2)

Application Number Title Priority Date Filing Date
HK02101648.2A HK1041518B (en) 1998-11-27 2002-03-04 Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract
HK02104333.6A HK1042745A1 (en) 1998-11-27 2002-06-08 Substance containing shiitake mushroom hypha extract for screening lak activity and method for screening lak activity by using the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK02104333.6A HK1042745A1 (en) 1998-11-27 2002-06-08 Substance containing shiitake mushroom hypha extract for screening lak activity and method for screening lak activity by using the same

Country Status (8)

Country Link
JP (1) JP4308350B2 (en)
KR (1) KR20010089498A (en)
CN (1) CN1314963C (en)
CA (1) CA2352614C (en)
GB (1) GB2360090B (en)
HK (2) HK1041518B (en)
TW (1) TWI222515B (en)
WO (1) WO2000033069A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103173379A (en) * 2011-12-22 2013-06-26 熊津食品有限公司 Novel microbe for red ginseng fermentation, red ginseng fermentation liquid using the microbe and red ginseng fermentation drink
CA2877356C (en) 2012-07-05 2021-05-11 Nutramax Laboratories, Inc. Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder
JP5847106B2 (en) 2013-03-25 2016-01-20 株式会社フジキン Pressure flow control device with flow monitor.
CA3220362A1 (en) 2021-05-26 2022-12-01 Brian CORNBLATT Compositions comprising sulforaphane or a sulforaphane precursor and moringa plant components

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2015294A1 (en) * 1989-04-28 1990-10-28 John J. Rinehart Generation and expansion of lak cells
US5198334A (en) * 1989-07-21 1993-03-30 Terumo Corporation Protection of natural killer cell cytolytic activity in peripheral blood mononuclear cells
US5108760A (en) * 1989-07-21 1992-04-28 Terumo Corporation Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
US5725855A (en) * 1991-04-05 1998-03-10 The United States Of America As Represented By The Department Of Health And Human Services Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
JP2002270532A (en) * 2001-03-14 2002-09-20 Tokyo Electron Ltd Heating device and thermal treatment apparatus

Also Published As

Publication number Publication date
HK1042745A1 (en) 2002-08-23
GB2360090A (en) 2001-09-12
TWI222515B (en) 2004-10-21
KR20010089498A (en) 2001-10-06
HK1041518A1 (en) 2002-07-12
JP4308350B2 (en) 2009-08-05
GB0112999D0 (en) 2001-07-18
CN1332847A (en) 2002-01-23
JP2000162204A (en) 2000-06-16
CA2352614C (en) 2009-03-10
CN1314963C (en) 2007-05-09
WO2000033069A1 (en) 2000-06-08
CA2352614A1 (en) 2000-06-08
GB2360090B (en) 2004-03-24

Similar Documents

Publication Publication Date Title
AUPP979599A0 (en) Shale compaction and sonic logs
AU5454500A (en) Magnetically enhanced composite materials and methods for making and using the same
AU8411198A (en) The induction of stress-related factors in plants
IL147803A0 (en) 28-epirapalogs
AU1595900A (en) Anti-cancer compounds and methods related thereto
AU2168597A (en) Improvements in or relating to encapsulation
AU3472300A (en) Vacuum-assisted laminator and methods of using the same
AU5822999A (en) Extraction articles and methods
AU7485000A (en) Method of making edge densified lumber and product of the method
KR100201051B1 (en) The method for culturing cordyceps
AU4636699A (en) Materials and methods relating to encapsulation
AUPO062596A0 (en) Improved mausoleum
AU4364897A (en) Improvements in or relating to the prophylaxis of breast cancer
AU1677199A (en) Improvements in or relating to ultrasonography
AU1588497A (en) The extract of pine needle and the use thereof
AU3932797A (en) Wood preservative
GB2360090B (en) Lak activity-screening materials containing Lentinus extract of edodes mycelium and lak activity-screening methods using the extract
MD798F1 (en) Method of the mamma cancer treatment
GB2359561B (en) LAK activity enhancers derived from extract of Lentinus edodes mycelium and LAKactivity-enhancing formulations containing the extract
GB2359562B (en) gamma delta T cell immunoactivity enhancers containing extract of Lentinus edodes mycelium
AU2390097A (en) Method for the preparation of pressed wood
AU2980799A (en) Lectomedin materials and methods
AU9276398A (en) Materials and methods relating to the stimulation of cells
AU5632500A (en) Cancer associated antigens and uses therefor
AU6200799A (en) Improving immune function

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAMES OF THE INVENTORS FROM HITOSHI NAGAOKA AND KOBAYASHI PHARMACEUTICAL CO LTD TO YUKIKO MATSUDA, YUTAKA TAJIMA AND KENJI ASANO

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101126